Streptococcus mutans, a dental caries pathogen, can promote systemic infections upon reaching the bloodstream. The two-component system (TCS) VicRK Sm of S. mutans regulates the synthesis of and interaction with sucrose-derived exopolysaccharides (EPS), processes associated with oral and systemic virulence. In this study, we investigated the mechanisms by which VicRK Sm affects S. mutans susceptibility to blood-mediated immunity. Compared with parent strain UA159, the vicK Sm isogenic mutant (UAvic) showed reduced susceptibility to deposition of C3b of complement, low binding to serum immunoglobulin G (IgG), and low frequency of C3b/ IgG-mediated opsonophagocytosis by polymorphonuclear cells in a sucroseindependent way (P<.05). Reverse transcriptase quantitative polymerase chain reaction analysis comparing gene expression in UA159 and UAvic revealed that genes encoding putative peptidases of the complement (pepO and smu.399) were upregulated in UAvic in the presence of serum, although genes encoding murein hydrolases (SmaA and Smu.2146c) or metabolic/surface proteins involved in bacterial interactions with host components (enolase, GAPDH) were mostly affected in a serumindependent way. Among vicK Sm -downstream genes (smaA, smu.2146c, lysM, atlA, pepO, smu.399), only pepO and smu.399 were associated with UAvic phenotypes; deletion of both genes in UA159 significantly enhanced levels of C3b deposition and opsonophagocytosis (P<.05). Moreover, consistent with the fibronectin-binding function of PepO orthologues, UAvic showed increased binding to fibronectin. Reduced susceptibility to opsonophagocytosis was insufficient to enhance ex vivo persistence of UAvic in blood, which was associated with growth defects of this mutant under limited nutrient conditions. Our findings revealed that S. mutans employs mechanisms of complement evasion through peptidases, which are controlled by VicRK Sm.
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| INTRODUCTION
Streptococcus mutans plays important functions in the assembly of cariogenic biofilms, which include secretion of glucosyltransferases required for the synthesis of insoluble exopolysaccharides (EPS) from sucrose. 1 Sucrose-derived EPS bound to glucan-binding proteins expressed on the S. mutans surface further reduces bacterial susceptibility to blood immunity, so accounting for the capacity of this microorganism to promote bacteremia. 2, 3 During the processes of host colonization or infection, S. mutans uses two-component systems (TCS) to sense and respond to environmental challenges. These transductional systems are typically composed by a sensor histidine kinase membrane protein and an intracellular response regulator. Thirteen or 14 TCS as well as the orphan response regulator called CovR (also known as GcrR) were identified in the available genomes of S. mutans. [4] [5] [6] The TCS VicRK Sm is of special interest because it regulates functions required for S. mutans cariogenicity and cell wall integrity. VicRK Sm -induced genes include those encoding the glucosyltransferases B (GtfB) and C (GtfC) (gtfB and gtfC, respectively)
for the synthesis of glucan EPS from sucrose, the glucan-binding protein B (GbpB) (gbpB) and the murein hydrolases LysM and SMU.2146c (lysM and smu2146c, respectively), which are involved in S. mutans interactions with EPS. [7] [8] [9] [10] On the other hand, VicRK Sm also strongly represses smaA, which encodes the murein hydrolase SmaA. 10 The general role of VicRK Sm as a modulator of cell division, cell wall biogenesis and interaction with EPS might explain the essentiality of this TCS for S. mutans viability, 8, 9, 11 increasing the interest in VicRK Sm as a therapeutic target to control S. mutans infections. 12 
| METHODS

| Studied strains, culture conditions, oligonucleotides, and construction of mutants
The studied strains are depicted in 
| C3b deposition on S. mutans strains
Deposition of C3b on the surface of serum-treated strains was determined as previously described 16 with some modifications. 
| Binding of serum IgG antibodies to S. mutans strains
Levels of serum IgG reactive with S. mutans were determined as previously described. 3 Briefly, bacterial strains at mid-log phase of growth were then harvested by centrifugation and suspended in 3% paraformaldehyde. Flow cytometry analyses were performed as described before, using forward and side scatter parameters to gate at least 25,000 bacteria. Bacterial samples treated with PBS instead of serum were used as negative controls.
| PMN isolation and opsonophagocytic assays
Isolation of human PMN from samples of fresh heparinized blood collected from a reference volunteer were performed as described elsewhere. 3 Cell viability (>98%) was monitored by trypan blue exclusion and cell purity (>95%) by May-Grunwald Giemsa staining. Bacteria applied in phagocytosis assays were labeled with FITC as previously described, 3 and aliquots were stored overnight in 10% glycerol at washed with cold saline, and total RNA was purified using RNeasy kit (Qiagen, Hilden, Germany). Samples were then treated with Turbo DNase (Ambion, Austin, TX), as previously described. 10 The cDNA was obtained from 1 μg of RNA using random primers 17 and
SuperScript III (Life Technologies), according to the manufacturer's instructions. Quantitative PCR was performed in a StepOne™ RealTime PCR System (Life Technologies) with cDNA (10 ng), 10 μmol L 17 Assays were performed in triplicate with three independent RNA samples.
| Binding of S. mutans strains to fibronectin
Fibronectin-binding assays were performed as previously described, 18 with modifications. 19 Briefly, human plasma fibronectin (SigmaAldrich) (50 μg mL 
| Analysis of the production of surface enolase and glyceraldehyde-3-phosphate dehydrogenase
Protein extracts from whole cells were obtained as previously de- Afterwards, these samples were 100-fold concentrated by lyophilization. 20 Protein concentration was determined using a Bradford assay kit (BioRad, Hercules, CA), according to the manufacturer's protocol. 
| Ex vivo survival of S. mutans strains in human blood
Bacterial survival in human blood was analyzed as previously described. 3 Briefly, cells from BHI cultures (A 550nm 0.3) were harvested (11 000 g, 2 minutes), washed twice in PBS, and resuspended in fresh whole human blood (1 mL) collected from the reference volunteer.
Samples were then incubated (37°C, 5% CO 2 , gentle agitation), and aliquots were collected at different time-points (from 0.5 to 24 hours), serially diluted and plated on BHI agar for determination of bacterial counts (CFU mL . Three independent experiments were performed in triplicate. 
| Statistical analyses
| RESULTS
| Deletion of vicK impairs deposition of C3b, binding to serum IgG and opsonophagocytosis by human PMN from peripheral blood
Previously, we observed that deletion of vicK in UA159 (UAvic) and in LT11 impaired phagocytosis by PMN in samples of human blood.
14 Because complement-mediated opsonization is crucial for efficient phagocytosis of S. mutans by PMN, 3 we compared the susceptibility of UA159, UAvic and UAvic+ to C3b deposition. As shown in Figure 1A , deposition of C3b was significantly impaired in UAvic when strains were treated with a reference serum, or with pooled sera, whereas
C3b deposition was completely restored in the complemented mutant 
| Deposition of C3b on UAvic is not influenced by sucrose-derived EPS
The major role of the TCS VicRK Sm in cariogenicity of S. mutans seems to be associated with transcriptional activation of genes required for the synthesis of and interaction with EPS derived from sucrose. 7, 10 Because the UAvic mutant has reduced production of sucrose-derived EPS and defects in biofilm formation, 9,10 it seems likely that reduced susceptibilities of this mutant to C3b deposition and IgG binding were not due to surface-associated EPS or to altered expression of surface components in response to sucrose. To address this issue, we compared levels of C3b deposition between strains grown in sucrose-free CDM and in complex BHI with strains grown in media (CDM and BHI)
supplemented with increasing amounts of sucrose. Because sucrosederived EPS bound to S. mutans blocks C3b deposition, 3 previous exposure of UA159 and UAvic+ to sucrose reduced levels of C3b deposition on these strains ( Figure 1D ). However, the UAvic mutant showed low levels of C3b deposition even when grown in sucrosefree CDM ( Figure 1D ). Hence, reduced susceptibility of UAvic to C3b deposition does not rely on sucrose-derived EPS or on altered responses to sucrose.
| VicRK Sm regulates cell surface biogenesis and complement evasion in the presence of serum
The VicRK Sm seems to be activated in response to cell wall stress, 9, 22 which might include interactions with host immune components, e.g.
pentraxins and complement proteins. 23 29, 30 which are shown in Table 3 . BLAST analyses of another 20 genes previously implicated in evasion to complement system in other species of streptococci and in Staphylococcus aureus, 31 did not reveal orthologues in S. mutans strains (data not shown).
As shown in Figure 2A , at mid-exponential growth, smaA was significantly upregulated in UAvic compared with UA159 in both conditions, absence (12.9-fold increase; analysis of variance with post hoc 
| The vicK mutant has increased binding to human fibronectin
The presence of fibronectin in serum might affect the course of the classical pathway of complement activation because it binds to the collagen-like domain of C1q. 34 Additionally, PepO of S. pneumoniae functions as a fibronectin-binding protein 35 and the gene encoding the PepO orthologue of S. mutans was upregulated in UAvic ( Figure 2C ). Therefore, we compared the ability of UAvic, UA159, and
UAvic+ to bind to human plasma fibronectin. As expected, the UAvic showed 5.4-fold increase (P<.01) in binding to fibronectin ( Figure 4A) whereas the complemented strain displayed wild-type binding levels ( Figure 4A ). Hence, our findings show that the TCS VicRK Sm modulates the ability of S. mutans to bind fibronectin.
| The vicK mutant has increased production of α-enolase, but not of extracellular GAPDH
Surface-associated GAPDH and α-enolase promote bacterial binding to fibronectin, plasminogen and/or other host glycoproteins of the extracellular matrix, including collagens and laminin. 36, 37 Although the mechanisms by which these glycolytic enzymes can be associated with 30, 38 Therefore, we compared levels of surface GAPDH and α-enolase in cell lysates and in culture supernatants of strains UAvic, UAsmaA, and UA2146c with parent and respective complemented strains. As shown in Figure 4B and C, when compared with UA159, whole cell extracts of the UAvic mutant at midlog phase have increased levels of α-enolase (4.8-fold increase; P<.05), which were restored to parental levels in the UAvic+ complemented strain. Levels of cell-associated α-enolase were not altered in the smaA and smu2146c mutants ( Figure 4C ). α-Enolase could not be detected in 100-fold concentrated culture supernatants of the strains analyzed, although high levels of GbpB (a secreted and surface-associated protein) 21 could be detected in the same samples in parallel immunoassays (data not shown). No significant changes in production of GAPDH were observed between the tested strains (data not shown). Hence, the vicK mutant shows overall increased production of α-enolase, although no significant levels of enolase and GAPDH could be detected in its culture supernatants.
| Deletion of vicK result in diminished survival of S. mutans in human blood, and reduced growth in poor nutrient medium
To persist in the bloodstream, bacteria must survive the host defenses and undergo physiological changes to adapt to nutrient limitations present in blood. 39 Therefore, we assessed the capacities of the UAvic mutant to persist in human blood and to grow in poor nutrient medium (RPMI). As shown in Figure 5A , over time, the numbers of viable UAvic recovered from blood in the survival assays were overall lower than those observed for UA159 and UAvic+, with 2 and 24 hours incubation periods showing statistically significant reductions compared with parent and complemented strains (P<.05). Survival of UAvic+ in blood was very similar to the parent strain. Comparisons of the growth curves of the studied strains in rich medium (BHI) revealed no alterations in growth rate in UAvic compared with UA159
( Figure 5B ). However, the UAvic showed significantly reduced growth rate in RPMI, when compared with UA159 and UAvic+ ( Figure 5C ).
The growth rate of UAvic+ was slower in both media when compared with UA159, probably because when growing UAvic+, the media were
Comparative analysis of transcriptional profiles of vicK mutant (UAvic) with parent strain UA159 in the presence and absence of serum. Strains at mid-and late-log phases of growth were harvested and exposed to brain-heart infusion (BHI) both or BHI supplemented with 20% human serum before RNA isolation. Relative amounts of transcripts of UA159 at each condition were set to 100% to calculate relative transcript levels obtained with UAvic at the same condition. VicRK Sm -downstream genes encoding murein hydrolases (A), metabolic enzymes (B) and peptidases of the complement (C) were analyzed. Columns represent means of three independent experiments; bars represent standard deviations. Asterisks indicate significant differences in relation to parent strain (analysis of variance with post hoc Dunnett's test; *P<.05)
supplemented with spectinomycin to maintain the plasmid expressing vicK Sm . Hence, the vicK mutant has a diminished capacity to persist in human blood compared with parent and complemented strains, which is associated with its defects in adaptation to limited nutrient conditions.
| DISCUSSION
Streptococcus mutans is an important species of viridans streptococci involved in cardiovascular diseases. 40, 41 Mechanisms of systemic virulence of S. mutans remain to be elucidated, but seem to involve expression of different genes in serotype-and strain-specific ways. cardiac endothelium and atheromatoses. 50, 51 The enhanced capacity of UAvic to bind to fibronectin is therefore compatible with the upregulation of pepO Sm in UAvic, and with resistance of this mutant to opsonophagocytosis. In S. mutans strain GS5, binding to fibronectin was associated with resistance to opsonophagocytosis and increased survival in the bloodstream, but this property was associated with the expression of atlA, 47 whose transcription was not significantly altered in UAvic (data not shown). In addition, S. mutans expresses other surface proteins that could contribute to fibronectin binding, 37 but their role in the UAvic phenotype remains to be elucidated.
Studies are under way to define the role of PepO Sm in systemic infections by S. mutans.
UAvic shows defects in septum division associated with reduced expression of GbpB, 9 an essential protein involved in S. mutans binding to EPS and in cell wall division. 9, 52 Downregulation of the GbpB orthologue (PcsB) in S. pneumoniae affects cell wall division 30 and promotes the release of enolase. 38 Enolase on S. pneumoniae surface binds to C4BP to inhibit complement activation. 53 Therefore, upregulation of enolase in UAvic could contribute to UAvic resistance to C3b deposition. Although we could not detect enolase in the culture supernatants of the studied strains, it is possible that extracellular enolase could be associated with the S. mutans cell wall.
The essentiality of VicR Sm regulator for S. mutans viability is not entirely understood. 7, 9, 10 In addition, vicK Sm -defective strains show increased sensitivity to oxidative, pH, and osmotic stresses. 9, 11, 25, 54 VicRK Sm is also responsive to nutritional changes, 11 and here we show that the vicK Sm mutant is defective in metabolic adaptation to limited nutrient conditions. All of these defects should reduce the capacity of In summary, in this study we showed that deletion of vicK reduces S. mutans susceptibility to phagocytosis by PMN by impairing C3b deposition and surface binding to serum IgG, in a way that is independent of the production of sucrose-derived EPS or of the expression of ) were expressed in relation to initial counts in blood suspension (time 0). Growth curves in brain-heart infusion (B) and in poor nutrient RPMI (C). Dots represent means of triplicate of one representative experiment. Bars indicate standard deviations. Differences in relation to parent strain at each time-point were tested using Kruskal-Wallis with post hoc Dunn's test with correction for repeated measures (*P<.05) murein hydrolases encoded by smaA and smu2146c. Two novel genes expressed by S. mutans under regulation of VicRK Sm were identified and were shown to contribute to S. mutans resistance to C3b deposition (pepO and smu.399), establishing that this bacterium expresses multiple factors associated with complement immunity evasion. Although deletion of vicK Sm results in increased resistance to opsonophagocytosis, it does not contribute to S. mutans survival in human blood, which is, at least in part, associated with defects in adaption to nutrient limitations.
